I agree Vin
The proposed range of uses for Oraline IV is very exciting.
And dont forget they will be adding other SBN products later on to their list.
Now that the FDA have an office in China, I bet they get the FDA approval once the 100,000 tests or trials are completed in China, what better proof or data will FDA receive than that.
It's a possible back door entry to FDA approval.
China's stamp of approval will go a long way.
- Forums
- ASX - By Stock
- SBN
- www.siyi.cc
www.siyi.cc, page-43
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online